| Stage | LEN.B | % of rev | LEN-B | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.0B | 100.00% | $8.0B | 100.00% | LEN.B ×1.00 |
| Gross profit | $619M | 7.69% | $619M | 7.69% | 0.0pp |
| Operating income | $460M | 5.71% | $460M | 5.71% | 0.0pp |
| Pre-tax income | $387M | 4.81% | $387M | 4.81% | 0.0pp |
| Net income | $285M | 3.55% | $285M | 3.55% | 0.0pp |
| Stage | LEN.B | LEN-B | Gap · A − B |
|---|---|---|---|
| Revenue | $8.0B100.00% | $8.0B100.00% | LEN.B ×1.00 |
| Gross profit | 7.69%$619M | 7.69%$619M | 0.0pp |
| Operating income | 5.71%$460M | 5.71%$460M | 0.0pp |
| Pre-tax income | 4.81%$387M | 4.81%$387M | 0.0pp |
| Net income |
| 3.55%$285M |
| 3.55%$285M |
| 0.0pp |
No disclosed counterparties: LEN.B, LEN-B.